Aqua Bio Technology ASA: Primary insider notification

16 Mar 2026 23:33 CET

Reference is made to the stock exchange notice from Aqua Bio Technology ASA
("ABTEC" or the "Company") published on 13 March 2026 regarding the
Extraordinary General Meeting approving a NOK 50 million debt conversion with
the issuance of 10,000,000 new shares (the "New Shares") in the Company, at a
subscription price of NOK 5.00 per New Share (the "Debt Conversion").

Expo Holding AS, a close associate of ABTEC board member Tonje Blaker, has
subscribed for and been allocated 1,891,892 New Shares in the Debt Conversion.
Following this and upon completion of the Debt Conversion, Expo Holding AS
holds 2,156,763 shares in the Company.

Please see the attached notification form for further information.

This information is subject to the disclosure requirements pursuant to MAR
article 19.

Contacts
Kristian Flaten
CEO & CFO
Aqua Bio Technology ASA

Phone: +47 9509 2322
Email: kf@aquabiotech.no

About Us
Aqua Bio Technology ASA (ABTEC) is a technology and distribution group in
skincare and nonfood. The group has distribution towards B2C and B2B, and
offers freight, customs, and logistics services. The group also develops
sustainable biotechnology for use in skincare products. Aqua Bio Technology is
listed on Euronext Expand Oslo.

This notice is published by Kristian Flaten on the listed date and time.

This information has been submitted pursuant to the Securities Trading Act §
5-12 and MAR. The information was submitted for publication, through the
agency of the contact persons set out above, at 2026-03-16 23:33 CET.

More information:
Access the news on Oslo Bors NewsWeb site

668508_260316 ABTEC KRT 1500 Expo Holding AS.pdf
668508_Aqua Bio Technology ASA- Primary insider notification.pdf